Review of research on pulmonary cysts in sjögren's syndrome.

Cai-Hong Pan, Xu-Fei Zhang, Chen Chen, Xiao-Bei An

Abstract readReview

In one paragraph

Review in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cai-Hong PanDepartment of Rheumatology and Immunology, The Third Hospital of Shijiazhuang, No. 15 South Sports Street, Chang'an district, Shijiazhuang, 050000, China.

Xu-Fei ZhangDepartment of Rheumatology and Immunology, The Third Hospital of Shijiazhuang, No. 15 South Sports Street, Chang'an district, Shijiazhuang, 050000, China.

Chen ChenDepartment of Rheumatology and Immunology, The Third Hospital of Shijiazhuang, No. 15 South Sports Street, Chang'an district, Shijiazhuang, 050000, China.

Xiao-Bei AnDepartment of Rheumatology and Immunology, The Third Hospital of Shijiazhuang, No. 15 South Sports Street, Chang'an district, Shijiazhuang, 050000, China. anxiaobei_xb@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sjögren's syndrome (SS) is a chronic systemic autoimmune disease mainly involving exocrine glands and particularly affecting the salivary glands and lacrimal glands, thus inducing a dry mouth and dry eyes. Extraglandular organs are also involved in SS, and this results in damage to multiple systems. Among these, lung damage is more common, with high morbidity and mortality rates, and the lack of typical symptoms in the early stages makes it challenging to identify it. The main pulmonary manifestations of SS are bronchitis, pulmonary hypertension, pulmonary cysts, pulmonary amyloidosis, interstitial pneumonia, and pulmonary fibrosis. Cystic lung disease affects about 4-46.2% of patients with SS. The imaging characteristics of pulmonary cysts in SS, including the size, number, morphology, and distribution, as well as differential diagnosis, mechanisms underlying the formation of pulmonary cysts, and current treatment strategies, are presented in this review.

Indexed as

CystsLung DiseasesSjogren's SyndromeHumansTomography, X-Ray ComputedDesquamative interstitial pneumoniaLymphocytic interstitial pneumoniaPulmonary cystPulmonary Langerhans cell histoplasmosisSjögren's syndrome

Identifiers

PMID40682117

DOI10.1186/s13019-025-03540-5

PMCPMC12273288

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.